Opendata, web and dolomites

CARDIACSENSE SIGNED

A new clinically proven and reliable medical solution for continuous heart arrhythmia and blood pressure monitoring

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CARDIACSENSE project word cloud

Explore the words cloud of the CARDIACSENSE project. It provides you a very rough idea of what is the project "CARDIACSENSE" about.

365    consists    save    connectivity    vision    hypertension    23    ischaemic    inflating    fibrillation    monitoring    movements    sharing    clinically    500    half    innovative    medical    pulse    atrial    time    launch    risk    800m    delivers    htn    vital    signs    health    costing    invasive    globally    data    introducing    5m    monitor    ltd    watch    2009    small    stroke    arrhythmia    lives    risks    device    accuracy    trl6    besides    finger    suffering    500bn    measuring    yearly    company    20    adults    proven    sense    cardiacsense    detects    precise    mainly    continuous    first    healthcare    solution    patients    market    finalize    jobs    bp    wrist    start    positive    free    obtrusive    optical    heart    wearable    surgery    storage    unaware    cardiac    signal    blood    revenues    lack    ppg    israeli    sensor    encountered    error    reliably    mostly    false    grade    boost    2025    individuals    pressure    sensitive    training    af    artefact   

Project "CARDIACSENSE" data sheet

The following table provides information about the project.

Coordinator
CARDIACSENSE 

Organization address
address: 4 LESHEM ST
city: CAESARA
postcode: 3079825
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website https://www.cardiacsense.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-12-01   to  2019-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CARDIACSENSE IL (CAESARA) coordinator 50˙000.00

Map

 Project objective

Atrial fibrillation (AF) is the most common heart arrhythmia in adults and a major risk factor for ischaemic stroke (increased by 500%), costing globally around €500Bn/year. On the other hand, Hypertension (HTN) is a condition, mostly encountered in patients suffering from AF, although only half of these individuals have this condition under control, and only 20% are unaware that they have HTN. Besides the health risks associated with these conditions, there is a lack of non-obtrusive, non-inflating, non-invasive, small, precise, easy-to-use devices for continuous monitoring of vital signs, including AF and blood pressure. Cardiac Sense Ltd is an Israeli start-up established in 2009, with a vision of developing innovative non-invasive technology for monitoring vital signs. We are developing CardiacSense (TRL6), a clinically-proven medical solution that reliably delivers non-invasive and non-inflating heart arrhythmia and blood pressure monitoring, 23/365 for as long as needed. It mainly consists of a wearable (a watch), highly sensitive, error-free (introducing an artefact sensor), real-time measuring device, that is non-invasive (no surgery needed), easy to use (no training needed) and allows for a great connectivity (providing easy data storage and sharing). Our solution is based on optical PPG sensor technology to monitor heart AF and BP. In addition, we are the first company to develop a unique artefact sensor that detects finger and wrist movements that affect the PPG signal by increasing false positive results. Our solution thus has a medical grade accuracy level of pulse measurement. Through this project we aim to finalize its development and launch it to the market, with a potential to save around €800M to EU healthcare and save up to 5,000 lives yearly, and to boost our company's growth to €7.5M revenues, and 20 new jobs by 2025.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CARDIACSENSE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CARDIACSENSE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

BeatsDigTherapeutics (2019)

Project SCALE: Tailored Digital Therapeutics for Neurological and Brain Disorders

Read More